ArticleBMC chemistry2025
2D CuO/rGO nanocomposite: a novel architecture for enhanced Cr(VI) photo-reduction.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synthesis of a TiOACS omega · 2026Article
- Ascorbic acid-mediated solid-state synthesis of cavity-engineered CuO-CuRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The urgent need for efficient detoxification of carcinogenic hexavalent chromium (Cr(VI)) in aquatic environments has driven the development of advanced photocatalytic materials. This study presents the synthesis of 2D CuO/reduced graphene oxide (rGO) nanocomposite via probe sonication, designed to synergistically enhance the photocatalytic reduction of Cr(VI) to less toxic Cr(III). The nanocomposite was meticulously characterized using XRD, HRTEM, FESEM, XPS, and UV-Vis diffuse reflectance spectroscopy. Structural analysis confirmed the formation of CuO nanosheets (average size: 396 nm, thickness: 6 nm) integrated with rGO, where the rGO acted as an electron acceptor, mitigating charge recombination. XPS revealed Cu²⁺ in CuO and Cu(OH)₂ phases, while FTIR confirmed interfacial interactions between CuO and rGO via oxygen functional groups. The CuO/rGO composite exhibited a reduced bandgap (1.35 eV → lower with rGO incorporation) and broad visible-light absorption, critical for photocatalytic activity. Under visible light, the composite achieved a remarkable 75% Cr(VI) reduction efficiency within 180 min triple that of pure CuO (25%) with a rate constant (0.007 min⁻¹) sevenfold higher. This enhancement is attributed to rGO role in facilitating electron transfer from CuO conduction band to its LUMO, minimizing electron-hole recombination. The composite demonstrated excellent recyclability over three cycles without significant efficiency loss. These findings underscore the potential of CuO/rGO as a robust, sustainable photocatalyst for environmental.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.